Table 1.
General approach | Specific method | Strengths | Weaknesses |
---|---|---|---|
Genetics | Selective breeding | Focus on phenotypes of interest | May produce a phenocopy of human disorder |
Random mutation and screening | Focus on phenotypes of interest | May produce a phenocopy of human disorder | |
Transgenic animals (e.g., knock-outs, knock-ins, overexpressors) | Recapitulates genetic abnormality in human disorder; Focus on gene of interest |
Variable penetrance of genetic abnormality in rodents. Human relevance of phenotype may be difficult to establish |
|
Virally mediated gene delivery to brain | Spatial and temporal control over genetic change; Focus on gene of interest |
Does not recapitulate genetic cause of human disorder | |
Pharmacological | Administration of neurotransmitter agonist or antagonist | Temporal and some spatial (with intracranial delivery) control; Focus on neurotransmitter system of interest |
Lack of evidence that common mental disorders involve selective lesions of a single neurotransmitter system |
Environmental | Chronic social stress (adult or during development) | May recapitulate risk factors in humans | Lack of specificity for a given human disorder |
Chronic physical stress | Easy to administer | Lack of construct validity for most human disorders | |
Electrical stimulation and lesions | Brain stimulation, including optogenetic approaches | Spatial and temporal control over neural circuit function; May recapitulate some findings in humans with DBS |
Current limitations in knowledge of neural circuit abnormalities in human disorder |
Anatomical lesions | May produce behavioral abnormalities reminiscent of human disorder | Lack of evidence for anatomical lesions as cause of human disorder |